Abstract
BackgroundAntibody-drug conjugates (ADC) are essential therapeutic options to treat solid and hematological cancers. The anti-epidermal growth factor-receptor (EGFR) antibody cetuximab (Cet) is used for the therapy of colorectal carcinoma (CRC)....
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have